PolyPid Secures $15 Million Non-Dilutive Secured Term Loan Facility

Operationg room
April 2022

Secured Loan facility with Kreos Capital Extends Company’s Cash Runway into the Second Quarter of 2023 PETACH TIKVA, Israel , April 06, 2022 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD ) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, announced

Contact Us

    Contact icon